Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)

Sinsin Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	748.44	539.85	346.46	2,240	799.33	2,504
Cash & Short-Term Investments	748.44	539.85	346.46	2,240	799.33	2,504
Cash Growth	-5.29%	55.82%	-84.53%	180.24%	-68.08%	77.61%
Accounts Receivable	33,665	30,605	27,975	25,771	23,237	22,526
Other Receivables	2,680	2,229	2,216	1,953	1,652	1,479
Receivables	36,346	32,833	30,191	27,724	24,889	24,005
Inventory	19,127	16,643	15,733	14,390	10,370	12,371
Prepaid Expenses	235.9	103.01	160.45	34.91	33.79	70.89
Other Current Assets	724.44	1,374	676.95	659.08	375.07	729.2
Total Current Assets	57,181	51,492	47,108	45,048	36,467	39,680
Property, Plant & Equipment	64,744	65,718	68,264	66,825	69,345	70,034
Long-Term Investments	7,772	6,649	3,270	3,559	3,183	3,180
Other Intangible Assets	571.96	580.53	586.32	592.29	499.07	499.07
Long-Term Accounts Receivable	-0	-0	-0	-0	-0	1.84
Long-Term Deferred Tax Assets	1,538	1,666	1,612	1,400	1,394	1,184
Other Long-Term Assets	3,072	3,379	3,570	3,790	3,418	3,555
Total Assets	134,879	129,484	124,409	121,213	114,307	118,134
Accounts Payable	6,540	7,256	7,060	6,815	4,746	6,911
Accrued Expenses	1,326	902.13	845.07	864.38	784.18	647.39
Short-Term Debt	23,190	20,706	16,142	11,794	12,720	9,916
Current Portion of Long-Term Debt	21,930	20,793	18,384	12,629	8,590	8,205
Current Portion of Leases	161.25	170.47	76.79	132.21	116.44	71.6
Current Income Taxes Payable	101.24	273.84	169.82	186.45	-	1,678
Other Current Liabilities	10,694	8,999	9,042	9,907	6,962	6,954
Total Current Liabilities	63,941	59,101	51,720	42,327	33,919	34,382
Long-Term Debt	1,947	3,822	9,843	18,865	24,676	26,857
Long-Term Leases	67.44	115.36	59.01	61.44	133.54	127.43
Other Long-Term Liabilities	983.63	877.82	696.83	313.31	580.1	210
Total Liabilities	66,949	63,915	62,319	61,682	59,507	62,086
Common Stock	7,585	7,585	7,585	7,585	7,585	7,585
Additional Paid-In Capital	14,450	14,450	14,450	14,450	14,450	14,450
Retained Earnings	46,291	44,875	41,019	37,478	32,890	34,150
Comprehensive Income & Other	-121.02	-1,037	-759.18	184.15	1.31	9.58
Total Common Equity	68,205	65,874	62,295	59,698	54,927	56,195
Minority Interest	-274.89	-304.86	-204.62	-166.81	-126.43	-147.38
Shareholders' Equity	67,930	65,569	62,090	59,531	54,800	56,048
Total Liabilities & Equity	134,879	129,484	124,409	121,213	114,307	118,134
Total Debt	47,295	45,606	44,505	43,481	46,236	45,177
Net Cash (Debt)	-46,547	-45,066	-44,158	-41,241	-45,437	-42,673
Net Cash Per Share	-3075.05	-2970.66	-2910.81	-2718.51	-2995.06	-2812.89
Filing Date Shares Outstanding	15.17	15.17	15.17	15.17	15.17	15.17
Total Common Shares Outstanding	15.17	15.17	15.17	15.17	15.17	15.17
Working Capital	-6,759	-7,608	-4,612	2,720	2,548	5,297
Book Value Per Share	4495.91	4342.22	4106.33	3935.14	3620.62	3704.24
Tangible Book Value	67,633	65,293	61,709	59,106	54,428	55,696
Tangible Book Value Per Share	4458.21	4303.95	4067.68	3896.09	3587.73	3671.34
Land	13,944	13,944	13,944	13,860	13,722	13,722
Buildings	38,007	44,477	44,264	44,093	43,922	43,138
Machinery	18,186	33,875	32,628	27,545	26,864	25,014
Construction In Progress	163.17	-	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.